reviewJournal of Cellular PhysiologyFeb 19, 2019Closed access

PD‐1/PD‐L1 pathway: Basic biology and role in cancer immunotherapy

Tabriz University of Medical Sciences · Mashhad University of Medical Sciences · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Over the course of past few years, cancer immunotherapy has been accompanied with promising results. However, preliminary investigations with respect to immunotherapy concentrated mostly on targeting the immune checkpoints, nowadays, emerge as the most efficient strategy to raise beneficial antitumor immune responses. Programmed cell death protein 1 (PD-1) plays an important role in subsiding immune responses and promoting self-tolerance through suppressing the activity of T cells and promoting differentiation of regulatory T cells. PD-1 is considered as an immune checkpoint and protects against autoimmune responses through both induction of apoptosis in antigen-specific T cells and inhibiting apoptosis in…

Citation impact

448
total citations
FWCI
23.31
Percentile
100%
References
129
Citations per year

Authors

7

Topics & keywords

Keywords
  • Immunotherapy
  • Immune system
  • Cancer immunotherapy
  • Immune checkpoint
  • Cancer research
  • Monoclonal antibody
  • Cancer
  • Immunology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.